Nectar Social | $10,600,000 | (Jun 6, 2025)
Voltrac | $2,286,772 | (Jun 6, 2025)
Signify Bio | $15,000,000 | (Jun 6, 2025) Certified by Founder
Lodge
Clarametyx Biosciences
start up
United States
- Columbus, Ohio
- 08/01/2024
- Series A
- $33,000,000
Clarametyx Biosciences Inc. is a clinical stage biotechnology company developing immune-enabling biologic therapies to fight life-threatening infections. Our novel technology platform targets the protective barrier around bacteria, known as biofilms.
- Industry Biotechnology Research
- Website https://clarametyx.com/
- LinkedIn https://www.linkedin.com/company/clarametyx-biosciences/about/
Related People
David V. RichardsFounder
United States -
Columbus, Ohio
Life sciences executive and entrepreneur with a passion for building transformative science into compelling companies. Focus on high patient need categories that hold the potential for broad impact on national and global health, with a personal interest in infectious disease, neurocognitive and genetic disorders.
Allay Therapeutics | $57,500,000 | (Jun 6, 2025)
Flank | $10,000,000 | (Jun 6, 2025)
Obvio | $22,000,000 | (Jun 5, 2025)
Manex AI | $9,142,230 | (Jun 5, 2025)
Filament Syfter | $4,800,000 | (Jun 5, 2025)
Vivrelle | $62,000,000 | (Jun 5, 2025)
Sema4.ai | $25,000,000 | (Jun 5, 2025)
Aive | $13,700,350 | (Jun 5, 2025)
Delpha | $2,000,000 | (Jun 5, 2025)